Clinical case of autoimmune thyroiditis after coronary angiography
Main Article Content
Abstract
Background. At present, the most objective and informative method of diagnosing stenotic coronary artery disease is coronary angiography, which is increasingly used in clinical practice. The purpose of the study is to analyze a clinical case of autoimmune thyroiditis before and after coronary angiography in order to improve the management of patients with thyroid pathology. Materials and methods. System analysis, bibliosemantics and case study of a particular patient. Searching for literature on databases: CyberLeninka, NCBI. Results. It is known that the use of large doses of iodinated contrast media leads to complications in the form of allergic reactions, toxic effects on the kidneys and thyroid gland. Researchers also note that thyroid dysfunction is more common in patients with a history of thyroid disease and in residents of iodine deficient regions. In our opinion, this category of patients should be classified as a highrisk group in terms of possible exacerbation and/or worsening of thyroid disease. So, before the coronary angiographic examination, it is necessary to control its morphofunctional state. Conclusions. The use of high doses of iodinated contrast media during coronary angiography, even with compensated pathology of the thyroid gland, has a high risk of developing its dysfunction in the form of autoimmune thyroiditis with thyrotoxicosis; therefore, it is recommended to monitor the morphological and functional state of the gland in this group of patients before and after coronary angiography with the purpose of early detection and adequate timely correction of diseases.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
References